Key statistics
On Friday, Actinium Pharmaceuticals Inc (7AY1:STU) closed at 0.98, 14.49% above the 52 week low of 0.856 set on Feb 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.945 |
|---|---|
| High | 1.01 |
| Low | 0.939 |
| Bid | 0.989 |
| Offer | 1.03 |
| Previous close | 0.957 |
| Average volume | 14.29 |
|---|---|
| Shares outstanding | 31.20m |
| Free float | 30.46m |
| P/E (TTM) | -- |
| Market cap | 36.81m USD |
| EPS (TTM) | -1.11 USD |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Press releases
- Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting
- Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025
